NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/09/2026
Back to search
Official data from USPTO
CARUNZAMO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CARUNZAMO
ST13
US500000079437487Class
1, 5, 42, 44
Filing
79437487
Registration
8290341
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
06/09/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
09/09/2025
Registration date
06/09/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2026
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
HARMON KENNEDY, HEATHER N
Law office
N20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Miltenyi Biotec B.V. & Co. KG
Representatives
Peter Sloane Leason Ellis LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiological and biochemical products for industrialscientificdiagnostic purposeschemicals for use in industry and science; chemical diagnostic reagents for industrial and scientific purposes; Biological preparations for use in industry and science; Biological diagnostic preparations for scientific or research use; biochemical preparations for use in industry and science; biochemical diagnostic preparations for scientific or research use; chemicalbiological and biochemical productschemical preparationsbiological preparationsbiological preparations for industrial or scientific use in separation processes for biological materialsnot for medical purposes; reagents for cell separationlabeling reagentsreagentsmediasubstances and ingredients for the preparation of mediachemical reagents for scientific purposes and not for medical purposes; reagents for the processingseparationisolationenrichmentdepletiondetectionscreeninganalysis and counting of chemical and biological materialschemical reagents for scientific purposes and not for medical purposes; chemical reagents with magnetic beads for scientific purposes; antibody reagents used for the detection of antigens in cells and tissueother than for medical or veterinary purposes; buffer solutions for use in analytical chemistry and chemical reagents for use with laboratory instrumentsseparation instrumentsanalysis instrumentsreactors and imaging instrumentsall for scientific purposes and not for medical purposes; chemical reagents for processing of biological materialbiological tissuebone marrowcellsblood and its components for scientific purposes and not for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical research laboratoriesother than for medical use; blood culture mediacell culture mediacell freezing mediaall for scientific purposes; chemical reagents for use in biotechnologyin biological treatment processes and in the biotechnology industryall for scientific or industrial purposes and not for medical purposes
Class 5
Pharmaceutical preparations for treating cancer and autoimmune diseases; medical preparations for the treatment of for treating cancer and autoimmune diseases; veterinary preparations for treating cancer and autoimmune diseases; Chemical reagents for medical or veterinary purposes; media and materials and ingredients for the preparation of mediaall for cell cultures for medical or veterinary purposes; Chemical reagents for the processingseparationisolationenrichmentdepletiondetectionscreeninganalysis and counting of biological materialsall for medical or veterinary purposes; chemical reagents with magnetic beadsantibody reagents used for the detection of antigens in cells and tissue for medical purposesall for medical or veterinary purposes; reagents for use with medical instrumentsseparation instrumentsanalysis instrumentsreactor and imaging instrumentsfor medical purposes; clinical medical reagents for the processing of biological materialbiological tissuebone marrowcellsblood and its componentsall for medical or veterinary purposes; culture media for cultivating human cells; cell culture mediadiagnostic reagents and preparationsall for medical and veterinary purposes; cell freezing mediaX-ray contrast agentscontrast agents for in-vivo imagingall for medical and veterinary purposes; pharmaceutical products for cellular therapy
Class 42
Services of medical researchpharmaceutical productionbiotechnological research laboratories; medical and pharmaceutical servicesnamely services of a medical research and pharmaceutical production laboratory in the fields of cell therapeutic agentscell compoundscell preparationcellular medicinesthe selectionstimulationactivation of cells
Class 44
Medical services in the field of extracorporeal plasma therapy; medical treatment servicesmedical services for the treatment of cancer or autoimmune diseases
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2026
PUBO
PUBLISHED FOR OPPOSITION
04/21/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/26/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
03/26/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/26/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
03/26/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/26/2026
RFNT
REFUSAL PROCESSED BY IB
03/05/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/03/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/03/2026
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/19/2026
RFRR
REFUSAL PROCESSED BY MPU
02/19/2026
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/24/2026
CNRT
NON-FINAL ACTION WRITTEN
01/23/2026
DOCK
ASSIGNED TO EXAMINER
01/22/2026
MAFR
APPLICATION FILING RECEIPT MAILED
12/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/20/2025
Continuous trademark protection
Get notified about every new filing that threatens CARUNZAMO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.